Calcium folinate pentahydrate
Stage IV Uterine Corpus Cancer AJCC v8
City of Hope Medical CenterSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Stage IV Uterine Corpus Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan M.D. Anderson Cancer Center | Phase 2 | BB |
Abexinostat Pamela Munster | Phase 1 | CC |
Inno-206 City of Hope Medical Center | Phase 1 | CC |
MITOMYCIN C City of Hope Medical Center | Phase 1 | CC |
FLUOROURACILUM City of Hope Medical Center | Phase 1 | CC |
Eloxatin City of Hope Medical Center | Phase 1 | CC |
FULVESTRANT Pamela Munster | Phase 1 | CC |
Talzenna M.D. Anderson Cancer Center | Phase 1 | CC |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →